Oxford BioMedica PLC (OXBDF)

[marcusl2]

If I can find these companies before mainstream investors or corporate acquirers, the upside is significant, making them great candidates for the core holdings bucket of the Fidelity UK Opportunities Fund .

https://www.fidelity.co.uk/markets-insights/viewpoints/world-leading-tech-stocks


Pharmaceutical research has always been an area of expertise in the UK, and occasionally I come across a company which offers the twin benefits of improving healthcare provision as well as giving shareholders a healthy glow. Oxford Biomedica , a company that through their unique LentiVector delivery platform allow gene therapies to be delivered safely to patients, a system that may revolutionise some areas of cancer treatments and degenerative diseases. This is a top 5 position at 3.3% of the fund.